Call Start: 11:00 January 1, 0000 11:57 AM ET

ProPhase Labs, Inc. (NASDAQ:PRPH)

Q1 2022 Earnings Conference Call

May 13, 2022, 11:00 AM ET

Company Participants

Ted Karkus – Chairman & Chief Executive Officer

Conference Call Participants

Yi Chen – H.C. Wainwright & Co.

Robert Titus – MRT Industries

Dennis Waldman – Barrett Productions

Kyle Krueger – Apollo Capital

Fred McDonald – Private Investor

Operator

Good day and welcome to the ProPhase Labs First Quarter 2022. Financial Results and Corporate Update Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal our conference specialists by pressing star then zero. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Ted Karkus, Chairman and CEO of ProPhase Labs. Please go ahead, sir.

Ted Karkus

Thanks so much, Matt. And thank you all for joining me this morning. Obviously, we had a great quarter, and I'll get into that in a moment, but of course I have to do the standard forward looking statements, which obviously is important. So here goes. Before we begin today's call, I want to advise everyone that today's conference call will contain forward-looking statements, including statements relating to our plans, expectations, future performance and future events, including statements regarding projected financial results for the second quarter of 2022, our expectations regarding the COVID-19 pandemic, future waves of the pandemic and continued demand for diagnostic testing, purse of funding; our plans to grow our diagnostic business, and expand our lab services, and our plans to grow our genomics businesses, build a WGS library and attract academic institutions, and our plans to develop a broad spectrum anti-viral OTC dietary supplement, and build a pharmaceutical division, and our expectations regarding the sufficiency of our cash or working capital.

These statements are subject to risks and uncertainties that could cause our actual results to differ materially from those suggested by the forward-looking statements. Additional information concerning factors that could cause our results to differ materially from these forward-looking statements are contained in the earnings release that we issued earlier today, as well as in our public filings with the SEC. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise except to the extent required by applicable law.